​

Eupraxia Pharmaceuticals Ownership | Who Owns Eupraxia Pharmaceuticals?

OverviewChart

Eupraxia Pharmaceuticals Ownership Summary

Eupraxia Pharmaceuticals is owned by 38.27% institutional investors, 14.70% insiders, and 47.03% retail investors.

EPRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEupraxia Pharmaceuticals38.27%14.70%47.03%
SectorHealthcare Stocks 42.54%10.82%46.64%
IndustryBiotech Stocks 45.21%10.75%44.04%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252792.86%12,813,323550.40%38127.17%22144.44%2-60.00%
Jun 30, 20251427.27%1,970,076-9.11%514.87%912.50%5150.00%
Mar 31, 20251122.22%2,167,59318.69%623.11%8100.00%2-50.00%
Dec 31, 2024912.50%1,826,2701.52%520.10%4-33.33%4-
Sep 30, 20248-1,798,9684.16%521.48%6-25.00%--

EPRX Ownership FAQ

Who Owns Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals shareholders are primarily institutional investors at 38.27%, followed by 14.70% insiders and 47.03% retail investors. The average institutional ownership in Eupraxia Pharmaceuticals's industry, Biotech Stocks , is 45.21%, which Eupraxia Pharmaceuticals falls below.

Does Blackrock own Eupraxia Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Eupraxia Pharmaceuticals.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools